Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pat, the press release of May 11 quite clearly stated that the Company received approval from the FDA to proceed with the efficacy study.
"Based upon this safety data, the U.S. food and Drug Administration (FDA) approved the study's advancement to the efficacy segment and the Company is currently recruiting patients into this portion of the trial."
An interesting week ahead. Last week we eclipsed the resistance level of 2.65 and the stock again moved into the "buy" recommendation for short term, medium and long term. The next resistance level is 2.77.
The conference call on Wednesday and the Tides presentation on Thursday have the potential to release new news but.............I am not counting on anything new. Hoping but not counting on it. If there is news it will be a surprise!
Chancellor: no good answer to your question. Their past press releases, etc have usually disappointed and have been followed by a drop in price. But if the conference call includes new unexpected news, it could push us over $3 in a hurry. Yesterday had a good buying opportunity below $2.60. That might have been the best opportunity.
Interesting that the announcement mentions triple negative and inflammatory breast cancer. I was worried that this project had been dropped but maybe, just maybe we could have something big on the horizon. Unfortunately the conference call is at 5:30 am in the west so I may opt for the replay.
I see no relationship to multi-level marketing and the rise of this public company listed on Nasdaq. To paint all businesses with a UTah connection as dishonest is like condemning Christians because the Ku Klux Klan is a Christian organization.
While I see something wrong with the way BPTH is being run, we have a viable company with huge potential.
No surprises here. The shorts smell blood in the water and are going after us. The pain isn't over. Support is now at 1.66. Hopefully the buyers will come in before that point but it is likely that we can buy below $2 soon.
I think I'm going to shut down and go fishing. The hatch is on for North Idaho rivers. GLTA.
Denny makes a valid point. The article was trivial and disclosed nothing new to me. We have all discussed on this board the problems and weaknesses of the company. Each of us have invested based on our own due diligence. Things have not changed. But short sellers have been alerted to the vulnerability of of the company. Hang in there and stay long.
It will take a brave investor to buy BPTH shares tomorrow. Are there any buyers out there at $2.48?
This is the kind of news that counts. A "Buy" recommendation from an analyst with a $5 price target. We are now (finally) seeing results from the IR firm. This will add buyers.
I agree Snug. I raised the question on April 07 but there was no more discussion. I suppose they justified the gift of options to the recent increase in share price.
Nothing we can do about it. My reward is the increased price from .25 to $2.75 but I paid for these shares.
What should we make of these "changes of beneficial ownership". It looks like the executives and the board all received a gift of options at $2.75. They think they can justify it with the recent increase in PPS but have ignored the delays in meeting guidelines. I do not agree that they deserve these bonuses. I invested in this company in 2009 with my retirement money. Where in the fuck is my bonus for that sacrifice?
Brett, you say "no sustained rally until BPTH........"
I must point out that the recent rally from Feb 16 to April 5 brought the stock from 1.35 to 3.19. That is a substantial 136% gain in about six weeks.
I share your frustration over the slow progress of this company but this has been one hell of a good rally. Let' hope it resumes.
SJ that unusual odor in the room is the smell of money. I like it but let's not get too giddy. Profit takers and perhaps short sellers(?) are rushing in.
BarChart has updated and lists the next resistance level at $3.19 but we all know the psychological significance of $3.00. It has been about a year and a half since we touched that level. Hopefully our new institutional investing friends will carry us through that barrier tomorrow.
This rally just keeps going on. There has been a major increase in volume with few down days since Feb 16 indicating new buyers, presumably institutional buyers to account for this much volume. No one can guess when this will end but let's all enjoy this while it lasts.
Of course he did the right thing. Investing 101 teaches: "when a stock doubles, sell 50%. Hold the rest for huge profits"
So, I bought the bulk of my shares for .25-.40 and I'm still holding because I expect more. I admit I did sell a significant number of shares in 2015, not as a strategy but to pay for my lifestyle.
In other words, if I lecture about discipline, feel free to ignore my advice.
I don't know how this company should be valued at this time but I am so happy that the PPS has doubled in the past six weeks. I feel 100% better after going off anti-depressants (dropping to $1.01 a few months ago was a real downer). Suddenly, skies are blue, retirement looks more secure and even Donald Trump can't scare me.
I feel that we are close to a day when profit taking looks attractive (but only for a small part of my investment).
Okay I was not really on anti depressants but I have felt stressed.
I watch Barcharts. It showed resistance at 2.04 and we have blown through that. Next resistance is 2.23. They rate BPTH as a 100% buy for short term, medium term and long term based on our present momentum.
"The trend is your friend" and it looks good now. I think we are finally seeing those "fourteen press releases" that Mr Nielsen talked about last year (eleven to go?).
The high volume this morning was from buyers, suggesting that they had knowledge or at least suspicions that something positive was about to happen. I have heard no new rumors but we are close to several events (beginning phase 2 of AML study, approval of study for breast cancer, IND approval for Bcl-2). Since these are expected events I doubt that we will get much of a bounce from those announcements. Something unexpected like formation of a partnership with a bigger company would produce a huge rally.
After the price reached $2.10, profit taking and perhaps short sellers jumped in to sustain the volume. It was reassuring that the price rebounded to 2.05 after dropping into negative territory.
So in other words I cannot answer your question but wanted to talk about it.
Good Morning BPTH! What is goin on? No news yet but something good is happening. Let's hope it continues and the shorts don't overwhelm us.
We have to be happy with the price trend. I expected the price would retreat after the last disappointment but we seem solid in the 1.80's despite some increase in short selling. From a technical view, we are doing well but still need that "big news" to push this thing up (maybe a big Pharma partner?).
It appears that some investors are more impressed with today's news than I was. Hooray for the rally!
The unexpected news leads to increased PPS while finishing a long term study gets priced in long before the news.
Today's news means nothing to investors as it will be years, maybe decades before we get to clinical trials with pancreatic cancer.
It is a significant sign of the potential for antisense drugs using a liposomal delivery system. So much potential for this company.
I am surprised that there were buyers today as it looks like there will be a much lower price within the next week.
BPTH2008, I understand the feeling. Assuming you are able to take profits, it is the rational thing to do. Personally, I'm going to hold on (the irrational thing to do).
Was anyone issued a parachute? Looks like we're headed for a hard landing!
I had no trouble getting on the BioPath website.
What if we cured cancer and nobody cared?
Our last rally ended at $2.00 and we are ready to bump up against that resistance again. I cannot see BPTH breaking through that number without news about the safety study and beginning phase 2.
Bar charts states that resistance is at $2.15 but my instinct sees it at $2.
I have to believe that the safety study is complete and the news is being held pending FDA review. No way to speed this process ?
You sold your freakin shares? What were you thinking? Actually, I sold 20k shares recently (after it fell from $2). But I'm holding the rest.
The rally continues. Assuming these are investors "in the know" we should be close to long awaited news. I'm betting on next week..............damn, wish I hadn't said that.
Bio-Path is on a roll. Today we even had a significant increase in volume to suggest this is real. The last rally reached $1.99 before succumbing to lack of news. Hopefully, news will greet us in the next week and carry this stock to the stratosphere (or at least $2.50-3.00). I have not heard rumors so this run-up may just be optimism by investors, but maybe, just maybe, phase 2 will actually begin soon.
Big finish today and increased volume. Bar charts now shows a buy short term, mid term and long term. The main thing is increased buy orders suggesting ..............something. I think we are getting close but who knows?
I think they were talking about new members to the scientific advisory board, not the board of directors. The chance for fast track approval will depend on review of the first 19 patients in phase 2.
Everything seems to be on track. The wait is painful.
I did not hear anything new in the presentation but I may have snoozed a bit. We are still waiting for results of cohort 8.
And watching and waiting...........and watching and waiting........................
Of course we're all nervous but not different than the past 24 months (or longer). Remember every week we are closer to news of cohort 8. Someday we will have news.
Eventually we get to phase II and can pray for a buyout.
dmoffat, thanks for posting the link. This is what we need......Get the message out and find investors, especially institutional investors.
I expected that the final patient in cohort 8 would be completed by the end of January and we are one week away from that goal. Since there has been no sign of news, I consulted Nate Silver (famous statistician who predicts political outcomes). According to Nate, the probability of an announcement before the end of month is 52%. ??????
Anybody else expect news next week?
With the stock market in free-fall, BPTH is looking like a "conservative " investment. It is trying to stay above 1.30 while waiting for news from the remaining patient in cohort 8.
After selling most of my portfolio except BPTH, I have cash but will fight the temptation to add more shares.
Is anyone looking at this as a "buying opportunity?"